✦ LIBER ✦

Estrogen-mediated immunosuppression in autoimmune diseases

✍ Scribed by L. Jansson; R. Holmdahl

Publisher: SP Birkhäuser Verlag Basel
Year: 1998
Tongue: English
Weight: 156 KB
Volume: 47
Category: Article
ISSN: 1420-908X
DOI: 10.1007/s000110050332

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunosuppressive therapy of autoimmune

Immunosuppressive therapy of autoimmune diseases

✍ Jean-François Bach 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 636 KB

Clinical use of immunosuppressants in au

Clinical use of immunosuppressants in autoimmune diseases

✍ James R. Seibold 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 491 KB

Interleukin-12, a key cytokine in Th1-me

Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases

✍ L. Adorini 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 175 KB

Xenobiotic immunosuppressive agents: the

Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases

✍ H. Burkhardt; J. R. Kalden 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 67 KB

Evidence for spontaneous immunosuppressi

Evidence for spontaneous immunosuppression in autoimmune hepatitis

✍ Ansgar Wilhelm Lohse; Matthias Kögel; Karl-Hermann Mermer Zum Büschenfelde 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 824 KB

Autoimmune hepatitis (AIH) runs a variable clinical course. Slow disease progression or even spontaneous remissions can be observed and suggest that the autoimmune process can, at least to a certain extent, be controlled by regulatory elements of the patient's own immune system. In experimental auto

Systemic antigen in the treatment of T-c

Systemic antigen in the treatment of T-cell-mediated autoimmune diseases

✍ Roland Liblau; Roland Tisch; Nadége Bercovici; Hugh O. McDevitt 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 394 KB